Gel Immersion Endoscopic Mucosal Resection With Submucosal Injection for Superficial Esophageal Squamous Neoplasms (With Video)

ABSTRACT Objectives Gel immersion can provide a stable immersion environment during endoscopic mucosal resection (EMR). However, its application in superficial esophageal squamous lesions remains limited. In this study, we evaluated a gel immersion EMR (GI‐EMR) technique in which submucosal injection was intentionally performed before snaring for selected small superficial esophageal squamous lesions. Methods This single‐center, retrospective case series included consecutive patients who underwent GI‐EMR with submucosal injection for superficial esophageal squamous lesions ≤15 mm in size between January and March 2026. The primary outcome was the histological en bloc resection rate, while secondary outcomes included technical success, endoscopic en bloc resection rate, procedure time, adverse events, and histopathological findings. Results GI‐EMR with submucosal injection was attempted for 13 lesions, achieving a technical success rate of 92% (12/13). One procedure was discontinued because adequate lifting could not be achieved due to post‐chemoradiotherapy scarring. The endoscopic and histological en bloc resection rates were both 85% (11/13) on an intention‐to‐treat basis. The median procedure time was 4.25 min (range, 2.0–11.0 min). No intraoperative or delayed perforation, post‐procedure bleeding, or gel‐related adverse events occurred. Conclusions GI‐EMR with submucosal injection was technically feasible for selected superficial esophageal squamous lesions ≤15 mm, with no serious procedure‐related adverse events observed in this small case series. Trial Registration N/A

Authors

Institutions

Publication Details

Journal
DEN Open
Published
2026-10-07
DOI
https://doi.org/10.1002/deo2.70444
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gel Immersion Endoscopic Mucosal Resection With Submucosal Injection for Superficial Esophageal Squamous Neoplasms (With Video)

Takeshi Takasago, Yuji Urabe, Yoshiki Hatsushika, Takeo Nakamura et al.
DEN Open
Esophageal Cancer Research and Treatment
article

Gel Immersion Endoscopic Mucosal Resection With Submucosal Injection for Superficial Esophageal Squamous Neoplasms (With Video)

Takeshi Takasago, Yuji Urabe, Yoshiki Hatsushika, Takeo Nakamura, Yukiko Sako, Yoshihiro Kishida, Akira Ishikawa, Shiro Oka, Yuki Kamigaichi, Takahiro Uda, Satoshi Masuda, Akiyoshi Tsuboi, Shinji Mii, Hidehiko Takigawa, Toshio Kuwai, Hidenori Tanaka, Yuichi Hiyama, Ken Yamashita, Tomoyuki Gurita
article en

Abstract

ABSTRACT Objectives Gel immersion can provide a stable immersion environment during endoscopic mucosal resection (EMR). However, its application in superficial esophageal squamous lesions remains limited. In this study, we evaluated a gel immersion EMR (GI‐EMR) technique in which submucosal injection was intentionally performed before snaring for selected small superficial esophageal squamous lesions. Methods This single‐center, retrospective case series included consecutive patients who underwent GI‐EMR with submucosal injection for superficial esophageal squamous lesions ≤15 mm in size between January and March 2026. The primary outcome was the histological en bloc resection rate, while secondary outcomes included technical success, endoscopic en bloc resection rate, procedure time, adverse events, and histopathological findings. Results GI‐EMR with submucosal injection was attempted for 13 lesions, achieving a technical success rate of 92% (12/13). One procedure was discontinued because adequate lifting could not be achieved due to post‐chemoradiotherapy scarring. The endoscopic and histological en bloc resection rates were both 85% (11/13) on an intention‐to‐treat basis. The median procedure time was 4.25 min (range, 2.0–11.0 min). No intraoperative or delayed perforation, post‐procedure bleeding, or gel‐related adverse events occurred. Conclusions GI‐EMR with submucosal injection was technically feasible for selected superficial esophageal squamous lesions ≤15 mm, with no serious procedure‐related adverse events observed in this small case series. Trial Registration N/A

DEN OpenVol. 7(1)
Hiroshima University (JP), Hiroshima University Hospital (JP)
Openalex Percentile: Top 9%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.